Enthera Pharmaceuticals Competitors and Similar CompaniesClear all
Enthera Pharmaceuticals's competitors and similar companies include MannKind Corporation, Hua Medicine, Novaremed and Kadimastem.
 Enthera Pharmaceuticals Enthera Pharmaceuticals is a company that develops a biotechnology platform designed to find new therapeutic approaches to treat diabetes and related gastrointestinal complication. |  MannKind Corporation MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for patients. |  Kadimastem Kadimastem is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells (hESCs). | |||
Founding Date | Founding Date 2016 | Founding Date 1991 | Founding Date 2011 | Founding Date 2017 | Founding Date 2009 |
Type | Type Private | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Milan, IT HQ Milan, IT Milan, IT | Locations Westlake Village, US HQ Danbury, US | Locations Shanghai, CN HQ Beijing, CN Wuhan, CN Hong Kong, HK | Locations Basel, CH HQ | Locations Ness Ziona, IL HQ |
Employees | Employees 225% increase | Employees 39513% increase | Employees 168 | Employees 10 | Employees 11 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $349m (FY, 2025) | Revenue (est.) ¥492.9m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $26.8m (FY, 2025) | Cost of goods ¥180.1m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $322.2m (FY, 2025) | Gross profit ¥1.6b (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income $5.9m (FY, 2025) | Net income ¥1.1b (FY, 2025) | Net income N/A | Net income (₪26.6m) (FY, 2024) |
Funding | |||||
Latest funding round | Latest funding round $ 32.8m (almost 6 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 2.6m (almost 7 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 32.8m | Total funding raised $ 200m | Total funding raised $ 242.4m | Total funding raised $ 13.3m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
MannKind Corporation
HQ
Westlake Village, US
Employees
395↑ 13% increase
MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for patients.
View company
Hua Medicine
HQ
Shanghai, CN
Employees
168
Hua Medicine (华领医药) is a drug development company.
View companyKadimastem
HQ
Ness Ziona, IL
Employees
11
Kadimastem is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells (hESCs).
View company